Kuoyuan Cheng

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Angiotensin Converting Enzyme

Top Venues

Science advances

Molecular systems biology

Cancer research

medRxiv : the preprint server for health sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Nishanth Ulhas Nair, Alejandro A Schäffer, Edward Michael Gertz, Kuoyuan Cheng, Johanna Zerbib, Avinash Das Sahu, Gil Leor, Eldad David Shulman, Kenneth D Aldape, Uri Ben-David, Eytan Ruppin
Chromosome 7 gain compensates for chromosome 10 loss in glioma. Cancer research (2024)
Nishanth Ulhas Nair, Kuoyuan Cheng, Lamis Naddaf, Elad Sharon, Lipika R Pal, Padma Sheila Rajagopal, Irene Unterman, Kenneth D Aldape, Sridhar Hannenhalli, Chi-Ping Day, Yuval Tabach, Eytan Ruppin
Cross-species identification of cancer resistance-associated genes that may mediate human cancer risk. Science advances 8 (31) (2022)
Kuoyuan Cheng, Laura Martin-Sancho, Lipika R Pal, Yuan Pu, Laura Riva, Xin Yin, Sanju Sinha, Nishanth Ulhas Nair, Sumit K Chanda, Eytan Ruppin
Genome-scale metabolic modeling reveals SARS-CoV-2-induced metabolic changes and antiviral targets. Molecular systems biology 17 (11) (2021)
Kuoyuan Cheng, Nishanth Ulhas Nair, Joo Sang Lee, Eytan Ruppin
Synthetic lethality across normal tissues is strongly associated with cancer risk, onset, and tumor suppressor specificity. Science advances 7 (1) (2021)
Ariel Israel, Alejandro A Schäffer, Assi Cicurel, Ilan Feldhamer, Ameer Tal, Kuoyuan Cheng, Sanju Sinha, Eyal Schiff, Gil Lavie, Eytan Ruppin
Identification of drugs associated with reduced severity of COVID-19: A case-control study in a large population. medRxiv : the preprint server for health sciences (2021)
Sanju Sinha, Kuoyuan Cheng, Alejandro A Schäffer, Kenneth Aldape, Eyal Schiff, Eytan Ruppin
In vitro and in vivo identification of clinically approved drugs that modify ACE2 expression. Molecular systems biology 16 (7) (2020)